Search for Clinical Trial Results
Amyloidosis - 257 Studies Found
Status | Study |
RECRUITING |
Study Name: Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation Condition: Transthyretin Cardiac Amyloidosis Date: 2024-09-30 Interventions: Tafamidis 61 mg by mouth daily for 12 months |
RECRUITING |
Study Name: Ultrasound Therapy In Cardiac Amyloidosis Condition: Amyloidosis Cardiac Date: 2024-09-30 Interventions: Use of high mechanical index ultrasound therapy with intravenous Definity contrast infusion |
NOT_YET_RECRUITING |
Study Name: Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis Condition: Light Chain (AL) Amyloidosis Date: 2024-09-30 Interventions: NXC-201 (formerly HBI0101) CAR-T is defined as autologous T cells transduced ex-vivo with anti-BCMA CAR retroviral vector encoding the chimeric antige |
COMPLETED |
Study Name: This Study Will Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin Amyloidosis Condition: Hereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed Phenotype Date: 2024-09-30 Interventions: 80 or 61 milligrams (mg) |
RECRUITING |
Study Name: The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis. Condition: Transthyretin Amyloidosis Date: 2024-09-30 Interventions: 99mTc-DPD scintigraphy |
RECRUITING |
Study Name: Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis Condition: Amyloidosis; Systemic Date: 2024-09-30 Interventions: AT-02 via IV infusion |
COMPLETED |
Study Name: Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR Condition: Transthyretin Amyloidosis Date: 2024-09-30 Interventions: Amyloid reactive protein used as imaging agent in whole body SPECT-CT imaging |